ArticleScientific reports2026
Multifunctional lactic acid bacteria from sugarcane juice with probiotic properties for gut adaptation, health benefits, food preservation and quality enhancement.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Antioxidant Potential of Probiotics and Postbiotics Derived from Lactic Acid Bacteria and Their Impact on Foods.Foods (Basel, Switzerland) · 2026Review
- Antimicrobial potential of bacteria isolated from sediment andFrontiers in microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lactic acid bacteria (LAB) are promising probiotics and natural biopreservatives, yet non-dairy sources remain underexplored. We identified four LAB from sugarcane juice−Limosilactobacillus fermentum SCJ26, Lactiplantibacillus plantarum SCJ27, L. fermentum SCJ28 and Lactiplantibacillus pentosus SCJ29, evaluated through an integrated “safety-to-application” framework. Unlike single-endpoint assessments, we combined gut-adaptation (acid, bile, phenol tolerance; adhesion traits), functional bioactivities (antimicrobial, antifungal, antioxidant, anti-biofilm), safety (antibiotic susceptibility, absence of hemolysis and DNase), and technological properties (EPS production, milk coagulation, biopreservation). SCJ28 and SCJ29 showed the highest simulated gastrointestinal survival, while SCJ26 and SCJ29 displayed superior aggregation and hydrophobicity. Functional bioactivities were strain-specific: SCJ27 produced inhibition zones up to ~ 20 mm against E. coli; SCJ29 reduced E. coli biofilm by ~ 53% and SCJ27 reduced S. aureus biofilm by ~ 70%; SCJ29 reached ~ 86% DPPH scavenging. Filtered supernatants effectively reduced microbial loads in food matrices, with reductions of up to 3.8 log10 in fish and 3.6 log10 in tomato. The isolates produced exopolysaccharides and coagulated milk, underscoring technological potential. None of the isolates exhibited hemolytic or DNase activity, and their antibiotic susceptibility profiles were typical for LAB, but warrant genomic follow-up to ascertain resistance traits are intrinsic. Overall, the LAB strains exhibited multifunctionality, supporting both health and food applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.